ORIG3N, a leader in regenerative medicine technology and consumer genetics assessments, has unveiled two new DNA tests focused exclusively on individuals' future development. The Company's DNA tests are designed to reveal genetic information that will remove some of the roadblocks along the path to optimal health. This will ease the frustration consumers often feel when identifying what will work best for their unique sensitivities, behavioral factors and more.
With ORIG3N's DNA tests customers can confirm things they always suspected about themselves, and discover things they never knew.
|Employees (est.) (Mar 2019)||39||(-9%)|
Orig3n total Funding
Orig3n latest funding size
Time since last funding
|8 months ago|
|Vectr Ventures, Spectrum Health Ventures, DEFTA Partners, Mountain Group Capital, Syno Capital, Harris & Harris Group, KTB Ventures, MMIC Investment Holdings, KTB-KORUS Fund, Haitong International Securities Group, 180 Degree Capital, Alexandria Venture Investments, Hatteras Venture Partners, LabCorp, MGC Venture Partners|
Orig3n has 27 Twitter Followers. The number of followers has increased 20% month over month and increased 45.3% quarter over quarter
When was Orig3n founded?
Orig3n was founded in 2014.
How many employees does Orig3n have?
Orig3n has 39 employees.
Who are Orig3n competitors?
Competitors of Orig3n include Audentes Therapeutics, Agendia and 23andMe.
Where is Orig3n headquarters?
Orig3n headquarters is located at Boston, MA, USA, Boston.
Where are Orig3n offices?
Orig3n has an office in Boston.
How many offices does Orig3n have?
Orig3n has 1 office.